Cundy Kenneth C 4/A
4/A · Anebulo Pharmaceuticals, Inc. · Filed Mar 8, 2024
Insider Transaction Report
Form 4/AAmended
Cundy Kenneth C
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2024-02-29+72,613→ 72,613 totalExercise: $2.72Exp: 2034-02-28→ Common Stock (72,613 underlying)
Footnotes (1)
- [F1]The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter beginning on April 1, 2024.